MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MGNX MacroGenics Inc.

盘后交易 07-02 19:16:18 EDT

4.10

-0.20

-4.65%

盘后4.12

+0.02+0.49%

18:47 EDT

最高4.29	最低4.03	成交量88.82万
今开4.28	昨收4.30	日振幅6.05%
总市值2.57亿	流通市值2.11亿	总股本6,263万
成交额364.26万	换手率1.72%	流通股本5,156万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MGNX","market":"US","secType":"STK","nameCN":"MacroGenics Inc.","latestPrice":4.1,"timestamp":1719950400000,"preClose":4.3,"halted":0,"volume":888230,"hourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.1,"latestTime":"18:47 EDT","volume":4244,"amount":17401.813252,"timestamp":1719960438134},"delay":0,"floatShares":51562682,"shares":62633460,"eps":-0.3816,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.2,"latestTime":"07-02 19:16:18 EDT","open":4.28,"high":4.29,"low":4.03,"amount":3642640.1122999997,"amplitude":0.060465,"askPrice":4.21,"askSize":300,"bidPrice":4,"bidSize":2280,"shortable":3,"etf":0,"ttmEps":-0.3816,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1719964800000},"adr":0,"listingDate":1381377600000,"adjPreClose":4.3,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.2785,"preClose":4.3,"latestTime":"09:20 EDT","volume":121,"amount":516.1860363,"timestamp":1719926430892},"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.1,"latestTime":"18:47 EDT","volume":4244,"amount":17401.813252,"timestamp":1719960438134},"volumeRatio":0.565879,"impliedVol":0.8635,"impliedVolPercentile":0.3651},"requestUrl":"/m/hq/s/MGNX","defaultTab":"news","newsList":[{"id":"2448161804","title":"Macrogenics, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448161804","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448161804?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:00","pubTimestamp":1719936045,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时00分，Macrogenics, Inc.股票出现波动，股价大幅跳水5.00%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703000045941f32ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703000045941f32ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2448416915","title":"Macrogenics, Inc.盘中异动 快速拉升5.18%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448416915","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448416915?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:00","pubTimestamp":1719842409,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时00分，Macrogenics, Inc.股票出现异动，股价大幅上涨5.18%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Senti Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.、Geovax Labs, Inc.较为活跃，换手率分别为233.75%、86.04%、75.80%，振幅较大的相关个股有Senti Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为68.88%、28.78%、28.45%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220010968186ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220010968186ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2446688026","title":"Macrogenics, Inc.盘中异动 早盘大幅拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446688026","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446688026?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:40","pubTimestamp":1719582014,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时40分，Macrogenics, Inc.股票出现波动，股价急速拉升5.34%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Carisma Therapeutics, Inc.较为活跃，换手率分别为294.52%、156.62%、25.43%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Carisma Therapeutics, Inc.，振幅分别为45.53%、29.56%、25.78%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214015af8fc37d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214015af8fc37d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2446944483","title":"Macrogenics, Inc.盘中异动 早盘股价大跌5.01%报4.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446944483","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446944483?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:20","pubTimestamp":1719411613,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时20分，Macrogenics, Inc.股票出现波动，股价快速跳水5.01%。截至发稿，该股报4.08美元/股，成交量12.3811万股，换手率0.20%，振幅4.43%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222013aef6c019&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222013aef6c019&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2446878306","title":"Macrogenics, Inc.盘中异动 股价大跌5.11%报4.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446878306","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446878306?lang=zh_cn&edition=full","pubTime":"2024-06-26 02:24","pubTimestamp":1719339891,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日02时24分，Macrogenics, Inc.股票出现异动，股价大幅跳水5.11%。截至发稿，该股报4.27美元/股，成交量64.9063万股，换手率1.04%，振幅4.78%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626022452941f0fb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626022452941f0fb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2445607702","title":"Macrogenics, Inc.盘中异动 早盘急速上涨5.03%报4.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445607702","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445607702?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:07","pubTimestamp":1719238058,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时07分，Macrogenics, Inc.股票出现波动，股价快速上涨5.03%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624220739941f0956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624220739941f0956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2443604489","title":"Macrogenics, Inc.盘中异动 下午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443604489","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443604489?lang=zh_cn&edition=full","pubTime":"2024-06-15 03:22","pubTimestamp":1718392932,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日03时22分，Macrogenics, Inc.股票出现波动，股价大幅下挫5.02%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615032212af8da6f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615032212af8da6f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2443126634","title":"Macrogenics, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443126634","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443126634?lang=zh_cn&edition=full","pubTime":"2024-06-14 02:05","pubTimestamp":1718301921,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日02时05分，Macrogenics, Inc.股票出现波动，股价大幅下跌5.31%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、乌龙制药涨幅较大，Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2688.71%、1286.34%、150.05%，振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为102.21%、82.05%、74.62%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061402052196814101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061402052196814101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","MGNX"],"gpt_icon":0},{"id":"2442569686","title":"Macrogenics, Inc.盘中异动 临近午盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442569686","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442569686?lang=zh_cn&edition=full","pubTime":"2024-06-12 23:38","pubTimestamp":1718206728,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日23时38分，Macrogenics, Inc.股票出现异动，股价急速拉升5.07%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061223384896813c49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061223384896813c49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","MGNX"],"gpt_icon":0},{"id":"2441177745","title":"Macrogenics, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441177745","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441177745?lang=zh_cn&edition=full","pubTime":"2024-06-06 22:39","pubTimestamp":1717684748,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日22时39分，Macrogenics, Inc.股票出现异动，股价快速下跌5.09%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606223908af8c6ccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606223908af8c6ccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2440549588","title":"Macrogenics, Inc.盘中异动 快速上涨5.38%报4.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440549588","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440549588?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:35","pubTimestamp":1717421705,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时35分，Macrogenics, Inc.股票出现异动，股价快速拉升5.38%。截至发稿，该股报4.31美元/股，成交量8.7172万股，换手率0.14%，振幅5.26%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213505af8ba6ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213505af8ba6ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2439952707","title":"Macrogenics, Inc.盘中异动 大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439952707","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439952707?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:47","pubTimestamp":1716990455,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时47分，Macrogenics, Inc.股票出现波动，股价大幅跳水5.07%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529214735aef2564c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529214735aef2564c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2439300943","title":"Macrogenics, Inc.盘中异动 股价大跌5.05%报4.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439300943","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439300943?lang=zh_cn&edition=full","pubTime":"2024-05-29 00:47","pubTimestamp":1716914875,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日00时47分，Macrogenics, Inc.股票出现异动，股价大幅跳水5.05%。截至发稿，该股报4.32美元/股，成交量47.5883万股，换手率0.76%，振幅8.13%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290047569681048a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290047569681048a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"gpt_icon":0},{"id":"2437775013","title":"MacroGenics Inc：Btig将目标价格从24美元下调至9美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437775013","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437775013?lang=zh_cn&edition=full","pubTime":"2024-05-24 12:45","pubTimestamp":1716525922,"startTime":"0","endTime":"0","summary":"MacroGenics Inc：Btig将目标价格从24美元下调至9美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405241245259556c8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405241245259556c8ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX"],"gpt_icon":0},{"id":"2437415292","title":"Macrogenics, Inc.盘中异动 急速拉升5.05%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437415292","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437415292?lang=zh_cn&edition=full","pubTime":"2024-05-22 23:00","pubTimestamp":1716390035,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日23时00分，Macrogenics, Inc.股票出现异动，股价快速上涨5.05%。截至发稿，该股报4.48美元/股，成交量34.8823万股，换手率0.56%，振幅5.99%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522230035861ee5fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522230035861ee5fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2436189060","title":"Macrogenics, Inc.2024财年第一财季实现净利润-52.19百万美元，同比减少37.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436189060","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436189060?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:06","pubTimestamp":1716048366,"startTime":"0","endTime":"0","summary":"3月31日，Macrogenics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-52.19百万美元，同比减少37.31%；其中营业收入为9.10百万美元，同比减少62.86%，每股基本收益为-0.84美元。机构评级：截至2024年3月31日，当前有10家机构对Macrogenics, Inc.目标价做出预测，其中目标均价为13.90美元，其中最低目标价为4.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190006168b15e339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190006168b15e339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX"],"gpt_icon":0},{"id":"2435731333","title":"Macrogenics, Inc.盘中异动 早盘快速拉升6.35%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435731333","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435731333?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:34","pubTimestamp":1715607241,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时34分，Macrogenics, Inc.股票出现波动，股价快速拉升6.35%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。其产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。消息层面，截至21时34分，Macrogenics, Inc.股票正面舆情新闻比例16.67%。该信息摘要如下：巴克莱：维持Macrogenics评级，由增持调整至增持评级, 目标价由25.00美元调整至14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213401876260ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213401876260ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"gpt_icon":0},{"id":"2434958768","title":"巴克莱：维持Macrogenics(MGNX.US)评级，由增持调整至增持评级, 目标价由25.00美元调整至14.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434958768","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434958768?lang=zh_cn&edition=full","pubTime":"2024-05-11 03:15","pubTimestamp":1715368522,"startTime":"0","endTime":"0","summary":"巴克莱：维持Macrogenics(MGNX.US)评级，由增持调整至增持评级, 目标价由25.00美元调整至14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110315268751e127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110315268751e127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.macrogenics.com","stockEarnings":[{"period":"1week","weight":-0.0444},{"period":"1month","weight":0.0513},{"period":"3month","weight":-0.6769},{"period":"6month","weight":-0.5683},{"period":"1year","weight":-0.1963},{"period":"ytd","weight":-0.553}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Macrogenics, Inc.于2000年8月14日在美国特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新型的以单克隆抗体为基础的疗法，用于治疗癌症和自身免疫性疾病。该公司通过其专有的一套下一代抗体技术平台，开发候选产品，并相信这个平台可以提高单克隆抗体和抗体衍生分子的性能。借助疾病生物学和免疫介导机制的知识，该公司已确定这些候选产品或许能应对现有疗法无法治疗的特定疾病所带来的挑战。公司既开发了针对新癌症靶点的分化分子，又提升了已上市药品的功效。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.011067},{"month":2,"riseRate":0.636364,"avgChangeRate":0.087848},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.042293},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.021288},{"month":5,"riseRate":0.363636,"avgChangeRate":0.018479},{"month":6,"riseRate":0.545455,"avgChangeRate":0.060585},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.031579},{"month":8,"riseRate":0.5,"avgChangeRate":0.025839},{"month":9,"riseRate":0.1,"avgChangeRate":-0.072899},{"month":10,"riseRate":0.5,"avgChangeRate":0.006912},{"month":11,"riseRate":0.727273,"avgChangeRate":0.14289},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.00459}],"exchange":"NASDAQ","name":"MacroGenics Inc.","nameEN":"Macrogenics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MacroGenics Inc.(MGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MacroGenics Inc.,MGNX,MacroGenics Inc.股票,MacroGenics Inc.股票老虎,MacroGenics Inc.股票老虎国际,MacroGenics Inc.行情,MacroGenics Inc.股票行情,MacroGenics Inc.股价,MacroGenics Inc.股市,MacroGenics Inc.股票价格,MacroGenics Inc.股票交易,MacroGenics Inc.股票购买,MacroGenics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MacroGenics Inc.(MGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}